JP2019509288A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019509288A5 JP2019509288A5 JP2018547294A JP2018547294A JP2019509288A5 JP 2019509288 A5 JP2019509288 A5 JP 2019509288A5 JP 2018547294 A JP2018547294 A JP 2018547294A JP 2018547294 A JP2018547294 A JP 2018547294A JP 2019509288 A5 JP2019509288 A5 JP 2019509288A5
- Authority
- JP
- Japan
- Prior art keywords
- optionally substituted
- alkyl
- hydrogen
- aryl
- group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- BGNUVVYDMAUNTM-UHFFFAOYSA-N Cc1ccc2[n]1nc(N)nc2N Chemical compound Cc1ccc2[n]1nc(N)nc2N BGNUVVYDMAUNTM-UHFFFAOYSA-N 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662305723P | 2016-03-09 | 2016-03-09 | |
| US62/305,723 | 2016-03-09 | ||
| PCT/US2017/021559 WO2017156262A1 (en) | 2016-03-09 | 2017-03-09 | Acyclic antivirals |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2019509288A JP2019509288A (ja) | 2019-04-04 |
| JP2019509288A5 true JP2019509288A5 (https=) | 2020-04-16 |
| JP6860585B2 JP6860585B2 (ja) | 2021-04-14 |
Family
ID=58361178
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018547294A Expired - Fee Related JP6860585B2 (ja) | 2016-03-09 | 2017-03-09 | 非環状抗ウイルス 優先出願の参照による組み込み |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US10745427B2 (https=) |
| EP (1) | EP3426642A4 (https=) |
| JP (1) | JP6860585B2 (https=) |
| CN (1) | CN109071467B (https=) |
| AU (1) | AU2017231824B2 (https=) |
| TW (1) | TWI740910B (https=) |
| WO (1) | WO2017156262A1 (https=) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR112015014457A2 (pt) | 2012-12-21 | 2017-11-21 | Alios Biopharma Inc | composto ou sal farmaceuticamente aceitável do mesmo e composição farmacêutica e respectivos usos e processos para melhorar ou tratar infecção de hcv, para inibir a atividade da ns5b polimerase do vírus da hepatite c e a replicação de vírus da hepatite c |
| AU2017231824B2 (en) | 2016-03-09 | 2021-07-01 | Alios Biopharma, Inc. | Acyclic antivirals |
| EP3515923A1 (en) * | 2016-09-23 | 2019-07-31 | Katholieke Universiteit Leuven | Prodrugs of fluorinated acyclic nucleoside phosphonates |
| EP3740209A1 (en) * | 2018-01-19 | 2020-11-25 | Gilead Sciences, Inc. | Metabolites of bictegravir |
| AU2019398792A1 (en) | 2018-12-12 | 2021-06-10 | Janssen Biopharma, Inc. | Cyclopentyl nucleoside analogs as anti-virals |
| BR112021010236A2 (pt) | 2018-12-12 | 2021-08-24 | Janssen Biopharma, Inc. | Análogos de ciclobutil nucleosídeos como antivirais |
| EP3914604B1 (en) | 2019-01-25 | 2026-03-04 | Brown University | Compositions comprising censavudine or elvucitabine for treating age-associated inflammation and disorders |
| JP2023500794A (ja) | 2019-10-17 | 2023-01-11 | エーアイ‐バイオファーマ | 抗ウイルス薬および肝臓標的薬 |
| TWI775313B (zh) | 2020-02-18 | 2022-08-21 | 美商基利科學股份有限公司 | 抗病毒化合物 |
| KR20250133471A (ko) | 2020-02-18 | 2025-09-05 | 길리애드 사이언시즈, 인코포레이티드 | 항바이러스 화합물 |
| TWI883391B (zh) | 2020-02-18 | 2025-05-11 | 美商基利科學股份有限公司 | 抗病毒化合物 |
| CN111909153B (zh) * | 2020-04-16 | 2021-11-19 | 山东鲁西药业有限公司 | 7-碘吡咯并[2,1-f][1,2,4]三嗪-4-胺的合成工艺 |
| CA3126560A1 (en) * | 2020-06-04 | 2021-12-04 | Waterstone Pharmaceuticals (Wuhan) Co., Ltd. | Treatment or prevention of coronaviridae infection |
| WO2022081823A1 (en) * | 2020-10-14 | 2022-04-21 | Temple University -Of The Commonwealth System Of Higher Education | Pharmacologic approach for suppression of coronaviruses |
| CA3216162A1 (en) | 2021-04-16 | 2022-10-20 | Gilead Sciences, Inc. | Methods of preparing carbanucleosides using amides |
| AU2022328698B2 (en) | 2021-08-18 | 2025-02-20 | Gilead Sciences, Inc. | Phospholipid compounds and methods of making and using the same |
Family Cites Families (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CS264222B1 (en) * | 1986-07-18 | 1989-06-13 | Holy Antonin | N-phosphonylmethoxyalkylderivatives of bases of pytimidine and purine and method of use them |
| US5432272A (en) | 1990-10-09 | 1995-07-11 | Benner; Steven A. | Method for incorporating into a DNA or RNA oligonucleotide using nucleotides bearing heterocyclic bases |
| US5532225A (en) * | 1992-07-31 | 1996-07-02 | Sri International | Acyclic purine phosphonate nucleotide analogs as antiviral agents, and related synthetic methods |
| US5877166A (en) * | 1996-04-29 | 1999-03-02 | Sri International | Enantiomerically pure 2-aminopurine phosphonate nucleotide analogs as antiviral agents |
| US6284748B1 (en) * | 1997-03-07 | 2001-09-04 | Metabasis Therapeutics, Inc. | Purine inhibitors of fructose 1,6-bisphosphatase |
| DE19912636A1 (de) * | 1999-03-20 | 2000-09-21 | Aventis Cropscience Gmbh | Bicyclische Heterocyclen, Verfahren zu ihrer Herstellung und ihre Verwendung als Herbizide und pharmazeutische Mittel |
| SK286630B6 (sk) | 2001-01-22 | 2009-02-05 | Merck & Co., Inc. | Nukleozidové deriváty, farmaceutický prostriedok s ich obsahom a ich použitie |
| PL374525A1 (en) * | 2001-11-14 | 2005-10-31 | Biocryst Pharmaceuticals, Inc. | Nucleosides preparation thereof and use as inhibitors of rna viral polymerases |
| FR2842809A1 (fr) | 2002-07-26 | 2004-01-30 | Greenpharma Sas | NOUVELLES PYRAZOLO[1,5-a]-1,3,5-TRIAZINES SUBSTITUEES ET LEURS ANALOGUES, COMPOSITIONS PHARMACEUTIQUES LES CONTENANT, UTILISATION A TITRE DE MEDICAMENT ET PROCEDES POUR LEUR PREPARATION |
| FR2850653A1 (fr) * | 2003-02-04 | 2004-08-06 | Univ Pasteur | Derives de pyrazolotriazine, procede de preparation et utilisations |
| CN1819832A (zh) * | 2003-04-25 | 2006-08-16 | 吉里德科学公司 | 激酶抑制性膦酸酯类似物 |
| KR20060022647A (ko) | 2003-04-25 | 2006-03-10 | 길리애드 사이언시즈, 인코포레이티드 | 키나아제 억제 포스포네이트 유사체 |
| US20050080053A1 (en) * | 2003-08-29 | 2005-04-14 | Biocryst Pharmaceuticals, Inc. | Nucleosides, preparation thereof and use as inhibitors of RNA viral polymerases |
| JP2007523180A (ja) * | 2004-02-17 | 2007-08-16 | エルジー・ライフ・サイエンシーズ・リミテッド | Ｈｉｖ感染治療に有用なヌクレオシドホスホネート誘導体 |
| AU2005330489B2 (en) * | 2004-07-27 | 2011-08-25 | Gilead Sciences, Inc. | Nucleoside phosphonate conjugates as anti HIV agents |
| JP5116687B2 (ja) | 2005-11-02 | 2013-01-09 | バイエル・ファルマ・アクチェンゲゼルシャフト | がんおよび他の過剰増殖性疾患の処置のためのピロロ［２，１−ｆ］［１，２，４］トリアジン−４−イルアミンＩＧＦ−１Ｒキナーゼ阻害剤 |
| WO2007064931A2 (en) | 2005-12-02 | 2007-06-07 | Bayer Healthcare Llc | Substituted 4-amino-pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis |
| MX2009007333A (es) * | 2007-01-12 | 2009-08-31 | Biocryst Pharm Inc | Analogos de nucleosidos antivirales. |
| CN101066981B (zh) * | 2007-05-25 | 2011-10-05 | 中国科学院上海药物研究所 | 非环核苷膦酸酯类化合物及其组合物、制备方法和用途 |
| CA2716856C (en) | 2008-03-20 | 2013-02-19 | Amgen Inc. | Aurora kinase modulators and method of use |
| HUE025528T2 (en) | 2008-04-23 | 2016-05-30 | Gilead Sciences Inc | 1'-substituted carba-nucleoside analogs for antiviral treatment |
| WO2010002877A2 (en) | 2008-07-03 | 2010-01-07 | Biota Scientific Management | Bycyclic nucleosides and nucleotides as therapeutic agents |
| CN102596958A (zh) * | 2009-09-21 | 2012-07-18 | 吉里德科学公司 | 用于抗病毒治疗的2’-氟代carba-核苷类似物 |
| JP6082033B2 (ja) | 2012-02-23 | 2017-02-15 | バイエル・インテレクチュアル・プロパティ・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツングＢａｙｅｒ Ｉｎｔｅｌｌｅｃｔｕａｌ Ｐｒｏｐｅｒｔｙ ＧｍｂＨ | 置換ベンゾチエニル−ピロロトリアジンおよびその使用 |
| UA119050C2 (uk) | 2013-11-11 | 2019-04-25 | Ґілеад Саєнсиз, Інк. | ПІРОЛО[1.2-f][1.2.4]ТРИАЗИНИ, ЯКІ ВИКОРИСТОВУЮТЬСЯ ДЛЯ ЛІКУВАННЯ РЕСПІРАТОРНО-СИНЦИТІАЛЬНИХ ВІРУСНИХ ІНФЕКЦІЙ |
| JP6338402B2 (ja) | 2014-03-07 | 2018-06-06 | 日東電工株式会社 | 樹脂フィルム |
| AU2017231824B2 (en) | 2016-03-09 | 2021-07-01 | Alios Biopharma, Inc. | Acyclic antivirals |
-
2017
- 2017-03-09 AU AU2017231824A patent/AU2017231824B2/en not_active Ceased
- 2017-03-09 US US16/090,715 patent/US10745427B2/en active Active
- 2017-03-09 CN CN201780028902.8A patent/CN109071467B/zh not_active Expired - Fee Related
- 2017-03-09 EP EP17764089.3A patent/EP3426642A4/en not_active Withdrawn
- 2017-03-09 JP JP2018547294A patent/JP6860585B2/ja not_active Expired - Fee Related
- 2017-03-09 WO PCT/US2017/021559 patent/WO2017156262A1/en not_active Ceased
- 2017-03-09 TW TW106107827A patent/TWI740910B/zh not_active IP Right Cessation
-
2020
- 2020-06-30 US US16/916,618 patent/US11472826B2/en active Active